Siguazodan (Standard)
Siguazodan (Standard) is the analytical standard of Siguazodan. This product is intended for research and analytical applications. Siguazodan (SKF 94836) is a potent, selective and orally active phosphodiesterase III (PDE-III) inhibitor with an IC50 of 117 nM. Siguazodan increases cAMP accumulation in intact platelets with an EC50 of 18.88 μM. Siguazodan also inhibits phenylephrine-induced 5-HT release with an IC50 value of 4.2 μM[1][2][3].
Product Specifications
CAS Number
115344-47-3
UNSPSC
12352100
Target
Phosphodiesterase (PDE) ; Reference Standards
Related Pathways
Metabolic Enzyme/Protease; Others
Field of Research
Cardiovascular Disease
Smiles
O=C1CC(C)C(C2=CC=C(/N=C(NC)/NC#N)C=C2)=NN1
Molecular Formula
C14H16N6O
Molecular Weight
284.32
References & Citations
[1]Tang KM, et al. Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitors. Eur J Pharmacol. 1994 Jun 15;268 (1) :105-14.|[2]Murray KJ, et al. The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function. Br J Pharmacol. 1990 Mar;99 (3) :612-6.|[3]Freitag A, et al. Phosphodiesterase inhibitors suppress alpha2-adrenoceptor-mediated 5-hydroxytryptamine release from tracheae of newborn rabbits. Eur J Pharmacol. 1998 Jul 31;354 (1) :67-71.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
117701A1-AAT 500 Tests
XFD750 Anti-non-human primates/ human CD177 Antibody *MEM-166*
Sign In for Pricing
View Details 
bsm-61236R-Cy3-TR 20 µL
Dysferlin Recombinant Antibody, Cy3 Conjugated
Sign In for Pricing
View Details 
RC201587L2V 200 µL
ORC4L (ORC4) (NM_002552) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details BNC041020-100 1x 100 µL
IGF-1 (IGF1/1020), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 